Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Endonovo Therapeutics Inc (ENDV)

Endonovo Therapeutics Inc (ENDV)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 8,526
  • Shares Outstanding, K 852,647
  • Annual Sales, $ 80 K
  • Annual Income, $ -6,440 K
  • 60-Month Beta 2.47
  • Price/Sales 103.76
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.02
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/12/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0060 +66.67%
on 09/24/19
0.0134 -25.37%
on 10/02/19
+0.0011 (+12.36%)
since 09/11/19
3-Month
0.0060 +66.67%
on 09/24/19
0.0155 -35.48%
on 07/19/19
-0.0044 (-30.56%)
since 07/11/19
52-Week
0.0060 +66.67%
on 09/24/19
0.0500 -80.00%
on 10/15/18
-0.0380 (-79.17%)
since 10/11/18

Most Recent Stories

More News
Endonovo Therapeutics Appoints Dr. William Li as Strategic Advisor to the CEO

Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announces it has appointed Dr. William Li as Strategic Advisor to the CEO. Dr. Li and Endonovo CEO Alan Collier will work collaboratively...

ENDV : 0.0100 (-0.99%)
Endonovo Partners with Veterans Healthcare Supply Solutions, Appoints Samir Awad, M.D., to Scientific Advisory Board

Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of noninvasive Electroceutical(R) therapeutic devices, today announces a partnership with Veterans...

ENDV : 0.0100 (-0.99%)
Endonovo Therapeutics Appoints Dr. Geoffrey Abrams of Stanford University to Its Scientific Advisory Board

via NetworkWire -- Endonovo Therapeutics Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of noninvasive Electroceutical therapeutic devices, today announces the appointment...

ENDV : 0.0100 (-0.99%)
Endonovo Therapeutics Announces Second Quarter Results

via NetworkWire - Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), today announces financial and operating results for the second quarter ended June 30, 2019.

ENDV : 0.0100 (-0.99%)
Endonovo Therapeutics Inc. Featured in Exclusive NetworkNewsWire Broadcast

via NetworkNewsAudio - Endonovo Therapeutics Inc. (OTCQB: ENDV), an innovative biotechnology company and commercial-stage developer of noninvasive Electroceutical(TM) therapeutic devices, today announces...

ENDV : 0.0100 (-0.99%)
Endonovo Therapeutics Appoints Dr. Peter Novak to its Scientific Advisory Board

via NetworkWire -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of noninvasive Electroceutical(TM) therapeutic devices, today announces the appointment...

ENDV : 0.0100 (-0.99%)
Endonovo Therapeutics Appoints Dr. Steven Levin of Johns Hopkins University to Its Scientific Advisory Board

via NetworkWire - Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical(TM) therapeutic devices, today announces the appointment...

ENDV : 0.0100 (-0.99%)
Coverage Initiated for Endonovo Therapeutics via NetworkNewsWire

via NetworkWire -- Endonovo Therapeutics (OTCQB: ENDV), an innovative biotechnology company developing a bioelectronic approach to regenerative medicine, today announces it has selected the corporate communications...

ENDV : 0.0100 (-0.99%)
Guitar Center, Inc. Announces Early Tender Results for Its Previously Announced Exchange Offer and Consent Solicitation Relating to Its 9.625% Senior Unsecured Notes Due 2020

Guitar Center, Inc. (the "Company") announced the early tender results for its previously announced exchange offer and consent solicitation (the "Exchange Offer") to (i) exchange its existing 9.625% Senior...

Endonovo Therapeutics Appoints Dr. Roc Alan McCarthy as a Scientific Advisory Board Member

Endonovo Therapeutics, Inc. (OTCQB: ENDV), today announced, that Roc Alan McCarthy, D.O. will be joining the company as a Scientific Advisory Board Member. Dr. McCarthy will help Endonovo continue to advance...

ENDV : 0.0100 (-0.99%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Soft. Long term indicators fully support a continuation of the trend.

See More Share

Trade ENDV with:

Key Turning Points

2nd Resistance Point 0.0107
1st Resistance Point 0.0104
Last Price 0.0100
1st Support Level 0.0097
2nd Support Level 0.0093

See More

52-Week High 0.0500
Fibonacci 61.8% 0.0332
Fibonacci 50% 0.0280
Fibonacci 38.2% 0.0228
Last Price 0.0100
52-Week Low 0.0060

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar